All In MedTech

FDA Clearance Tracker · P030006-S013

PROLIEVE THERMODILATATION SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 20, 2007 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Nov 20, 2007

Approved

Time to decision

211 days

Received Apr 23, 2007. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P030006-S013
Device name
PROLIEVE THERMODILATATION SYSTEM
Applicant location
Columbia, MD
Received
Apr 23, 2007
Decided
Nov 20, 2007
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol - OSB
Original approval
P030006

Device type

Device class
Class III

Every decision under product code MEQ

FDA's approval statement

As written in FDA's record.

APPROVAL OF THE POST-APPROVAL STUDY.

Source documents

Other decisions for Medifocus, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.